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1. Introduction  
Gastric ulcer disease remains widespread; a stressful lifestyle and non-steroidal anti-
inflammatory drugs (NSAIDs) make significant contributions to this pathological situation 
(Glavin et al., 1991; Hawkey, 2000; Laine et al., 2008). Despite indubitable advances in 
elucidation of the pathogenesis of gastric ulceration, there are gaps in our understanding of 
ulcerogenesis, particularly the role of key hormonal system of adaptation: the hypothalamic-
pituitary-adrenocortical (HPA) axis.  
2. Glucocorticoid hormones and gastric ulceration  
Glucocorticoid hormones and gastric ulceration have been discussed in many contexts. The 
action of acute and chronic treatment of patients or experimental animals with 
glucocorticoids as well as the effects of basal and stress-induced glucocorticoid production 
on the gastric mucosa has been considered. Although there is a long-standing debate over 
whether glucocorticoid therapy by itself leads to peptic ulcer disease in human (Luo et al., 
2009; Olsen et al., 2010), it is established that administration of glucocorticoids to 
experimental animals can result in an acute gastric erosion (Bandyopadhyay et al., 1999, as 
cited in Filaretova et al., 2009b; Black, 1988, as cited in Filaretova et al., 1998; Takeuchi et al., 
2008). In the same time, in some cases administration of glucocorticoids to animals can 
attenuate gastric erosion (Derelanko & Long 1982; Filaretova et al., 2009b; McCafferty et al., 
1995). It is also known that basal glucocorticoid production contribute to the maintenance of 
the gastric mucosal integrity (Takeuchi et al., 1989). The glucocorticoids may modulate the 
cytoprotective effect of adrenal catecholamines (Hernandez et al., 1984). They may have a 
permissive role in allowing gastroprotective mechanisms to exert their full potential. A 
permissive role was suggested in gastric mucosal protection induced by prostaglandins 
(PGs), sulfhydryls, cimetidine (Szabo et al., 1983) or interleukin-1 (Perretti et al., 1992).  
The most controversial question is the question about the action of stress-produced 
glucocorticoids. Based on the notion that exogenous glucocorticoids used at 
pharmacological doses have ulcerogenic properties, the increase of glucocorticoids during 
stress was also considered to be an ulcerogenic factor. In the same time, it is known that 
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glucocorticoid hormones released during acute stress-induced activation of the HPA axis 
help the body overcome negative effects of stress stimuli (Munk et al., 1984, as cited in 
Filaretova et al., 1998). Despite this knowledge, it has been generally accepted for several 
decades that stress-produced glucocorticoids cause an ulcerogenic response in the stomach, 
and stress-induced activation of the HPA axis is considered a pathogenic component of this 
response.  
As the widely held view about the ulcerogenic role of glucocorticoids released during stress 
is difficult to reconcile with the adaptive role of the HPA axis hormones, we designed 
experiments in rats to clarify the validity of this view. The results obtained do not support 
the traditional paradigm and suggest that glucocorticoids released during acute activation 
of the HPA axis are important gastroprotective factors. In the chapter, we review our results 
on the role of glucocorticoids in gastroprotection.  
2.1 Gastroprotective action of stress-produced glucocorticoids 
Various stressful stimuli activate the HPA axis, and consequently, the production of 
glucocorticoids, and severe stress stimuli may also induce gastric erosion, called “stress 
ulcers”. Hans Selye, the "Father" of the field of research into stress, attracted attention to 
these signs of stress. His greatest contributions were the demonstration of the stress triad 
(gastrointestinal ulceration, thymico-lymphatic atrophy, and adrenal hypertrophy) and of 
the role of the hypothalamus in activating the hypophysis, which, in turn, stimulates the 
adrenals to produce corticoids (Selye, 1967). From the very outset, researchers have focused 
on the idea that stress-generated glucocorticoids are causally related with gastric 
ulcerogenesis. This possibility was also investigated in hypophysectomized and 
adrenalectomized animals by Selye himself, who observed that although stress-induced 
thymico-lymphatic atrophy was inhibited in these animals, “stress ulcers” were not 
prevented, and concluded that the formation of “stress ulcers” depends on not only the 
pituitary-adrenal axis but other factors as well. He also proposed that neurostimulators play 
a major role in stress-induced ulcerogenesis, although high levels of corticoids in blood 
could be a sensitizing factor (Selye, 1967). Weiss (Weiss, 1971, as cited in Filaretova et al., 
1998) found in rats that the severity of stress-induced ulceration is positively correlated with 
the level of corticosterone in plasma and proposed that "steroids, in quantities that the 
animal is capable of secreting, may contribute to the production of ulcers". Further support 
for this idea came from the observation that animals with hippocampal lesions had 
increased levels of plasma corticosterone and developed more gastric ulcers during stress 
(Murphy et al., 1979, as cited in Filaretova et al., 1998). One approach used to support the 
view that stress-generated glucocorticoids are ulcerogenic was a groundless extrapolation of 
the ulcerogenic properties of exogenous glucocorticoids observed at high pharmacological 
doses to the properties of endogenous glucocorticoids released during stress.  
From the beginning (Filaretova, 1990), we have focused on the idea that glucocorticoids 
released during acute stress also have an adaptive effect on the stomach and, therefore, are 
gastroprotective rather than ulcerogenic. To test this hypothesis, we examined the effect of 
glucocorticoid deficiency or the glucocorticoid receptor antagonist RU-38486 on water and 
immersion-restraint-induced or cold-restraint-induced gastric erosion in rats (Filaretova, 
1990, 2006; Filaretova et al., 1998). Different approaches were used to inhibit the stress-
induced release of corticosterone: the inhibition of corticotropin-releasing hormone 
synthesis in the hypothalamic paraventricular nucleus by intrahypothalamic implantation of 
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dexamethasone, the immunoneutralization of ACTH by pretreatment with ACTH 
antiserum, and the inhibition of the HPA axis at the hypothalamic and the pituitary levels 
by pretreatment with a pharmacological dose of cortisol one week before stress. 
Corticosterone replacement, that is, the injection of corticosterone at a dose mimicking the 
stress-induced rise in corticosterone (4 mg/kg) 15 min before stress, was used in our 
experiments.  
Intrahypothalamic dexamethasone implantation significantly decreased the stress-
induced increase in corticosterone and markedly provoked the gastric erosion caused by 
stress. Corticosterone replacement prevented the aggravating effect of dexamethasone on 
the ulceration. ACTH antiserum administered shortly before cold-restraint stress 
decreased the release of corticosterone in response to stress and enhanced the severity of 
the gastric erosion (Filaretova et al., 1998). Pretreatment with glucocorticoid (cortisol) at a 
pharmacological dose caused an inhibition of the HPA axis at the hypothalamic and 
pituitary levels via a negative feedback mechanism and resulted in a long-lasting decrease 
in the stress-induced rise in corticosterone levels (Filaretova, 2006; Filaretova et al., 2001a). 
It is important to emphasize that animals were stressed one week after the treatment with 
cortisol when the exogenous hormone had already been eliminated but the corticosterone 
response to stress was still inhibited. The cortisol pretreatment increased the ulcerogenic 
action in both models of stress, and acute corticosterone replacement that mimicked the 
stress-induced corticosterone response reduced gastric erosion in rats with an inhibited 
HPA axis (Filaretova, 1990, 2006). These results support the idea that the gastric 
ulcerogenic response to stress is potentiated by a reduction of stress-induced 
glucocorticoid production.  
Glucocorticoid antagonists offer another way to demonstrate the role of the stress-induced 
rise in corticosterone in the gastric ulcerogenic response to stress. The specific 
progesterone/glucocorticoid receptor antagonist RU-38486 is known to bind with a high 
affinity to type II glucocorticoid receptors and may influence peripheral as well as central 
glucocorticoid receptors (Moguilewski & Philibert, 1984, as cited in Filaretova et al., 1998). In 
the simultaneous presence of glucocorticoids and the antagonist in vivo, glucocorticoid 
receptors are predominantly occupied by the antagonist (Alexandrova, 1994). The RU-
38486-glucocorticoid receptor complex is incapable of nuclear translocation and does not 
produce a biological effect (Moguilewski & Philibert, 1984, as cited in Filaretova et al., 1998). 
For this reason the glucocorticoid receptor antagonist RU-38486 can be a tool for 
investigating modes of glucocorticoid action. It was found that the occupation by RU-38486 
of glucocorticoid receptors during cold-restraint stress aggravates the stress-induced gastric 
erosion (Filaretova et al., 1998). We believe these results support the gastroprotective role of 
glucocorticoids released during stress. These data also suggest that gastroprotective action 
of glucocorticoids may occur, at least partly, through the classical genomic mechanism. 
There is also evidence that glucocorticoids can act through nongenomic pathways 
(Whitehouse, 2011). We do not rule out that nongenomic mechanisms may also be involved 
in gastroprotective action of glucocorticoids. 
To investigate contribution of glucocorticoids to the maintenance of gastric mucosal 
integrity during stress we predominantly used ulcerogenic stress models, although in some 
cases we also used non-ulcerogenic stress models. Using the ulcerogenic models we 
demonstrated that glucocorticoids released in response to the ulcerogenic stimuli attenuated 
their harmful action on the gastric mucosa. Our data obtained from the non-ulcerogenic 
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models suggests that mild stress stimuli don’t damage the gastric mucosa due to 
physiologic gastroprotective action of glucocorticoids released in response to these stimuli 
(Filaretova, 1990; Filaretova et al., 2001a). Indeed, we showed that in rats with glucocorticoid 
deficiency normally non-ulcerogenic stress stimulus turns into an ulcerogenic one 
(Filaretova, 1990). Another striking demonstration of the physiological gastroprotective role 
of glucocorticoids is the participation of glucocorticoids in gastroprotective effects of 
preconditioning stress (Filaretova et al., 2008). Preconditioning mild stress may attenuate 
gastric injury caused by severe stress and this effect is known to be mediated by PGs 
(Tanaka et al., 2007). It is known that mild stressors induce an increase in glucocorticoid 
production, however, it remained unknown whether glucocorticoids released during 
preconditioning mild stress contribute to the gasroprotective effect of mild stress against 
severe stressors. The contribution of glucocorticoids to the protective effect of 
preconditioning mild stress on gastric mucosa has not been investigated previously, 
apparently due to the prevailing traditional point of view on ulcerogenic action of 
glucocorticoids released during stress. Our findings about gastroprotective role of 
glucocorticoids produced during ulcerogenic stress allowed us to hypothesize that 
glucocorticoids contribute to gastroprotective effect of preconditioning non-ulcerogenic 
stress. To verify the hypothesis we compared the effects of mild stress on gastric erosion 
caused by severe stress in rats with normal and deficient corticosterone response to 
preconditioning mild stress. To inhibit glucocorticoid synthesis during mild stress 
metyrapone was injected shortly before the onset of mild stress. Metyrapone pretreatment 
caused a fast inhibition of corticosterone response to mild stress and prevented its protective 
effect on gastric ulceration induced by severe stress. The results obtained argue for a 
participation of glucocorticoids in the protective influence of preconditioning mild stress on 
gastric mucosa (Filaretova et al., 2008). We consider this fact as a further support for the 
point of view that glucocorticoids released during an acute stress are naturally occurring 
gastroprotective factors.  
Therefore, our data allows us to conclude that an acute stress-induced increase of 
glucocorticoids has gastroprotective action against stress-induced gastric damage. It should 
be emphasized that our studies on the mode of gastroprotection by glucocorticoids have 
been performed on animals during acute ulceration. The effects of glucocorticoids on the 
gastric mucosa during chronic stress conditions may be different from those observed in 
acute experiments. 
2.2 Gastroprotective action of glucocorticoids during treatment with non-steroidal 
anti-inflammotary drugs  
According to our results (Filaretova et al., 2001b, 2002a), NSAID treatment, similar to stress, 
may activate the HPA axis. Administration of both indomethacin and aspirin induced a 
release of corticosterone, which in turn may help to protect the gastric mucosa against 
NSAIDs. Indeed, adrenalectomy prevented NSAID-induced corticosterone release and 
markedly worsened the gastric erosion caused by NSAIDs. Acute corticosterone 
replacement, mimicking the indomethacin- and aspirin-induced rise in corticosterone, also 
prevented the aggravation of gastric ulcers generated by adrenalectomy (Filaretova et al., 
2002a). The aggravation of NSAID-induced gastric erosion was also demonstrated in 
another model of glucocorticoid deficiency where the NSAID-induced corticosterone rise 
was prevented by pharmacological blockade of the HPA axis (Filaretova et al., 2001b, 2005). 
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Likewise, pretreatment of the animals with RU-38486, the glucocorticoid receptor 
antagonist, significantly aggravated the severity of gastric erosion induced by indomethacin 
as well as aspirin (Filaretova et al., 2002a). It is thus assumed that endogenous 
glucocorticoids released during NSAID treatment increase the resistance of the gastric 
mucosa to NSAID-induced injury. 
The gastric ulcerogenic properties of NSAIDs limit the use of these drugs for the treatment 
of chronic inflammatory disorders, and it has been considered that combined treatment with 
therapeutic doses of glucocorticoid increases the risk of gastric ulceration (Hawkey, 2000). 
The results obtained in our studies (Filaretova et al., 2001b, 2002a, 2005) suggest that the 
increased risk of adverse gastric reactions should be considered when NSAIDs are used in 
patients with impaired glucocorticoid production. 
Endogenous glucocorticoids may have a permissive role in allowing gastroprotective 
mechanisms against NSAID-induced injury to exert their full beneficial potential. This 
action was suggested in gastric mucosal protection against aspirin-induced erosion induced 
by cimetidine (Szabo et al., 1983) or interleukin-1 (Perretti et al., 1992). Likewise, a normal 
basal production of glucocorticoids is also important for the gastric mucosa to resist 
indomethacin- (Takeuchi et al., 1989) or aspirin-induced damage (Perretti et al., 1992). 
Furthermore, both aspirin and indomethacin at ulcerogenic doses stimulate glucocorticoid 
production to cause an acute elevation of glucocorticoid content in the physiological range, 
which in turn protects against gastric damage induced by these NSAIDs.  
These data together with our previous findings support the point of view that 
glucocorticoids released during acute activation of the HPA axis caused by stress or NSAIDs 
as well as other ulcerogenic stimuli (Filaretova et al., 2001a) act as gastroprotective 
hormones. From the beginning (Filaretova, 1990), we have focused on the hypothesis that 
glucocorticoids released during stress also have an adaptive effect on the stomach. The 
results obtained in our studies confirm this hypothesis and furthermore demonstrate that 
glucocorticoids released in response to NSAIDs or other ulcerogenic stimuli also have an 
adaptive effect on the stomach. In turn, it means that an acute HPA axis activation is a 
physiologic gastroprotective component of acute stress response. 
It is known that both humoral and neuronal factors, such as PGs, nitric oxide (NO), and 
capsaicin-sensitive afferent neurons, play a pivotal role in the defense against gastric 
mucosal injury (Holzer, 1998; Wallace, 1997). They contribute to gastroprotection by 
modulating mucosal blood flow, mucus secretion, and repair of injured gastric mucosa. We 
showed that glucocorticoids released in response to ulcerogenic stimuli are naturally 
occurring gastroprotective factors and exert many of the same actions in the stomach as PGs, 
NO, and capsaicin-sensitive afferent neurons. This has prompted us to consider the 
interaction between glucocorticoid hormones and other protective factors in the 
maintenance of gastric mucosal integrity.  
We compared the effects of the drug-induced inhibition of PG or NO production or the 
desensitization of capsaicin-sensitive sensory neurons on the gastric mucosa in rats with 
deficient or with normal glucocorticoid production, under normal or ulcerogenic conditions. 
Indomethacin at 35 mg/kg (s.c.) was used as an ulcerogenic stimulus. The glucocorticoid 
deficiency was caused by adrenalectomy one week before the experiment. Two kinds of 
corticosterone replacement were used in adrenalectomized rats. Indomethacin at a 
nonulcerogenic dose (5 mg/kg i.p.) or L-NAME (50 mg/kg s.c.) was acutely given to inhibit 
PG and NO production, respectively. For the desensitization (functional ablation) of 
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capsaicin-sensitive afferent neurons, rats were given subcutaneous injections of capsaicin in 
3 consecutive doses of 20, 30, and 50 mg/kg (Bobryshev et al., 2005; Filaretova et al., 2007). 
Adrenalectomy by itself did not cause damage in the stomach. Neither inhibition of PG or 
NO, nor sensory deafferentation by itself provoked any damage in the gastric mucosa of 
sham-operated rats. However, each of these treatments damaged the gastric mucosa in 
adrenalectomized rats, and all of these responses were prevented by corticosterone in 
drinking water at a concentration mimicking the basal corticosterone level in normal rats 
(Bobryshev et a., 2005; Filaretova et al., 2007).  
Indomethacin-induced gastric erosion was aggravated to a similar extent by adrenalectomy, 
inhibition of NO production, or desensitization of capsaicin-sensitive afferent neurons. 
These data suggest that the role of glucocorticoid hormones in protection of the gastric 
mucosa against indomethacin is no less significant than that of NO or capsaicin-sensitive 
afferent neurons. The combination of adrenalectomy with inhibition of NO production or 
sensory deafferentation markedly potentiated the aggravating effect of these treatments by 
themselves on indomethacin-induced gastric erosions: the mean erosion area was increased 
approximately 5 or 10 times, respectively. Corticosterone at a dose mimicking the 
indomethacin-induced corticosterone rise totally prevented the aggravating effect of 
adrenalectomy in these experiments (Bobryshev et al., 2005; Filaretova et al., 2007). These 
results demonstrate that the effect of inhibition of NO production or sensory deafferentation 
on indomethacin-induced gastric erosion is significantly modified by glucocorticoid 
deficiency. This, in turn, suggests the important role of glucocorticoid hormones in the 
maintenance of gastric mucosal integrity under adverse conditions when the 
gastroprotective action of NO or capsaicin-sensitive neurons is impaired.  
Thus, our data demonstrates a pivotal compensatory role of glucocorticoids in the 
maintenance of gastric mucosal integrity in the case of impaired gastroprotective 
mechanisms provided by PGs, NO and capsaicin-sensitive afferent neurons. The 
compensatory gastroprotective role of glucocorticoids during PG deficiency (Filaretova et 
al., 2002a) or desensitization of capsaicin-sensitive afferents (Bobryshev et al., 2005) may be 
provided through enhancement of their production in these situations. We also showed that 
glucocorticoid deficiency, in turn, induces a compensatory enhancement in PG production 
in the stomach through COX-2 expression, which contributes to maintain the gastric 
mucosal integrity (Filaretova et al., 2002b). These date allowed us to conclude that there is 
some cooperative interaction between glucocorticoids and PGs in gastroprotection, in a way 
that a deficiency of one protective factor can lead to an apparently compensatory increase of 
the other. The gastric mucosa becomes more susceptible to injury during deficiency of both 
glucocorticoids and PGs (Filaretova et al., 2002b). This finding is important for clinical 
practice, especially for NSAID users. This further supports a warning that the increased risk 
of adverse gastric reactions should be considered when NSAIDs are used in patients with 
impaired glucocorticoid production. 
It has been suggested that “PGs, NO, and sensory neuropeptides act in concert in the 
maintenance of mucosal viability” (Whittle et al., 1990). The suggestion was confirmed and 
reinforced by other investigations. Our data adds new information to such a “concerted” 
modulation of the gastric mucosal integrity and suggests that glucocorticoids are also 
important participants in this modulation. According to the data the ability of 
glucocorticoids protect the gastric mucosa seems especially important for the maintenance 
of gastric mucosa when the protective mechanism provided by PGs or NO or capsaicin-
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sensitive afferent neurons is impared. We consider this fact as a striking manifestation of 
adaptive role of glucocorticoids.  
2.3 Mechanisms of gastroprotective action of glucocorticoids: the maintenance of 
gastric mucosal integrity through the maintenance of general body homeostasis  
There may be multiple targets for glucocorticoids to exert their beneficial influence on the 
gastric mucosa. We demonstrated that the gastroprotective action of glucocorticoids is 
provided by the maintenance of gastric mucosal blood flow, mucus secretion and repair 
processes as well as the attenuation of pathogenic elements such as the enhanced gastric 
motility (Filaretova et al., 1999, 2001b, 2002b,c, 2004). Anti-inflammatory properties of 
glucocorticoids may also contribute to their gastroprotective action. Glucocorticoids as anti-
inflammatory hormones may contribute to gastroprotection by inhibition of neutrophil 
adherence (Wallace, 1997) and attenuation of microvascular permeability (Filaretova et al., 
2002c). 
Because the glucocorticoid receptors are expressed ubiquitously it is possible that 
glucocorticoids may act directly on local gastric targets as well as using a more general 
mechanism. The contribution of glucocorticoids to the maintenance of gastric mucosal 
integrity may be closely related with their contribution to general body homeostasis 
(Filaretova et al., 2006). General homeostasis’s various links can be primary targets of 
glucocorticoid action and, therefore, the maintenance of general body homeostasis by 
glucocorticoids may be the base for their action on the maintenance of gastric mucosal 
integrity. The following facts support this statement. 
Glucocorticoids participate in maintaining normal blood glucose level that is especially 
important for the brain. There is a close relationship between HPA axis activity and blood 
glucose regulation. Hypoglycemia is the major trigger that activates the HPA axis and leads 
to enhancement of glucocorticoid production (Erturk et al., 1998, as cited in Filaretova et al., 
2006). Glucocorticoids increase hepatic gluconeogenesis, inhibit glucose uptake in 
adipocytes and fibroblasts, sensitize the liver to glucagon and epinephrine, decrease the 
hepatic sensitivity to insulin and, as a result, they increase blood glucose level (Chan et al., 
2002). In turn, maintaining the normal blood glucose level is important for the maintenance 
of gastric mucosal integrity. Insufficient supply of glucose may stimulate hypothalamic 
glucose-sensitive neurons (Mobbs et al., 2001, as cited in Filaretova et al., 2002c), resulting in 
a vagally-mediated increase in gastric motility and secretion (Shiraishi, 1988, as cited in 
Filaretova et al., 2002c) that are well-known pathogenic elements in various gastric 
ulcerogenic models. Exogenous glucose reverses the hypoglycemia-induced stimulation of 
hypothalamic glucose-sensitive neurons (Oomura et al., 1974, as cited in Filaretova et al., 
2002c), inhibits vagally-mediated gastric hypermotility (Barnett & Owyang, 1988, as cited in 
Filaretova et al., 2002c) and attenuates gastric ulceration (Takeuchi et al., 1990, as cited in 
Filaretova et al., 2002c). It was reasonable to assume that the maintenance of glucose 
homeostasis by glucocorticoid hormones could be fundamental to their beneficial actions on 
local gastric targets.  
The data obtained from the model of indomethacin-induced ulceration demonstrates that 
the maintenance of glucose homeostasis by glucocorticoids is responsible for their beneficial 
actions on gastric motility. Although the mechanisms by which indomethacin induces 
gastric injury involves multiple, closely interacting elements such as depletion of PGs, 
gastric hypermotility, microcirculatory disturbances, neutrophil-endothelial cell interactions 
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and superoxide radicals (Takeuchi et al., 1991; Wallace, 1997), gastric hypermotility may be 
a key element in the pathogenesis of indomethacin-induced gastric damage (Takeuchi et al., 
1989). The glycoprivic response is involved in the mechanism of gastric hypermotility 
induced by NSAIDs (Mersereau & Hinchey, 1982, as cited in Filaretova et al., 2002c). To 
understand the mechanisms underlying glucocorticoids’ gastroprotective actions against 
indomethacin-induced injury, we investigated the effect of adrenalectomy, with or without 
corticosterone replacement, on gastric motility and blood glucose level 4 hours after 
administration of indomethacin at the ulcerogenic dose. We confirmed (Filaretova et al., 
2002c) that indomethacin significantly enhanced gastric motility in sham-operated rats, and 
this hypermotility response was significantly aggravated in adrenalectomized rats, in 
parallel with an increase in gastric lesion score (Takeuchi et al., 1989). These results support 
a causal relationship between gastric hypermotility and lesion formation following 
administration of indomethacin. Blood glucose levels were low in adrenalectomized rats 
and decreased further after administration of indomethacin. This suggests a relation 
between low blood glucose levels, enhanced gastric motility and ulcerogenic responses to 
indomethacin. Indeed, adrenalectomized rats (with deficiency of corticosterone) given 
indomethacin showed minimum blood glucose levels, maximum gastric motility index 
values and maximum gastric lesion score when compared to sham-operated indomethacin-
treated group (Filaretova et al., 2002c). A single injection of corticosterone to 
adrenalectomized animals, at the dose imitating the indomethacin-induced rise in 
corticosterone, restored blood glucose levels and significantly reduced gastric hypermotility 
and ulcerogenic responses to indomethacin, whereas these beneficial effects of 
corticosterone was attenuated by a glucocorticoid receptor antagonist RU-38486 (Filaretova 
et al., 2002a,c). The findings suggest that there is close relationship between the 
gastroprotective action of glucocorticoids and their attenuation of gastric hypermotility 
through maintaining blood glucose level.  
The contribution of glucocorticoids to general body homeostasis involves their beneficial 
influences on cardiovascular system. The major actions of glucocorticoids on cardiovascular 
system are to enhance vascular reactivity to other vasoactive substances and to maintain 
systemic blood pressure (Darlington et al., 1989, as cited in Filaretova et al., 2006; Grunfeld 
& Eloy, 1987). Glucocorticoid deficiency is associated with reduced response to 
vasoconstrictors such as norepinephrine and angiotensin II. The latter stage of 
glucocorticoid deficiency is associated with cardiovascular collapse and heart failure in 
mammals after various stressors (Cleghorn, 1983, as cited in Filaretova et al., 2006). 
Glucocorticoid replacement is crucial in the treatment of patients with adrenal crisis, 
including the patients with Addison’s disease (Darlington et al., 1989, as cited in Filaretova 
et al., 2006). On the contrary, glucocorticoid excess induces hypertension in human and rats. 
Hypertension is seen in patients with excessive glucocorticoid secretion, occurring in most 
patients with Cushing’s syndrome and in patients with glucocorticoid treatment (Nieman et 
al., 1985, as cited in Filaretova et al., 2006). It was reported that a patient with Cushing’s 
syndrome was treated successfully with glucocorticoid receptor antagonist RU-38486 at high 
dose (Nieman et al., 1985, as cited in Filaretova et al., 2006). Experimental data obtained in 
adrenalectomized animals with or without glucocorticoid replacement (Darlington et al., 
1989; Darlington & Tehrani, 1997, as cited in Filaretova et al., 2006) as well as in rats with 
occupation of glucocorticoids receptors by RU-38486 (Grunfeld & Eloy, 1987, as cited in 
Filaretova et al., 2006) confirm and further develop clinical observations about the important 
contribution of glucocorticoid hormones to the regulation of blood pressure.  
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Under certain conditions, maintaining blood pressure is especially important for the 
maintenance of gastric mucosal integrity. There is evidence showing the linear correlation 
between the graded systemic hypotension and the mucosal blood flow as an important 
defensive factor (Guth, 1992). It was hypothesized that the blood flow to the stomach, a 
nonessential organ, decreases more rapidly and at an early stage of graded hypotension, in 
order to maintain blood flow to the essential organs such as the brain and kidney. The 
decrease in submucosal and mucosal blood flow during stress is an important factor, 
leading to mucosal ischemia, impairment in tissue resistance, and subsequent ulceration in 
stressed animals (Guth, 1992; Tarnasky et al., 1990). These facts allow us to assume that 
maintaining systemic blood pressure by glucocorticoids may be fundamental to their 
beneficial action on gastric blood flow and, consequently, on gastric mucosal integrity. 
Utilizing an in vivo microscopy technique for the direct visualization of the gastric 
microcirculation (Filaretova et al., 1999) as well as methods creating the alterations in 
glucocorticoid supply, we examined whether gastric microcirculation and arterial blood 
pressure are involved in the mechanism of gastroprotective action of glucocorticoids during 
3 hour water immersion-restraint stress. To this end the effects of deficiency of 
glucocorticoid production followed by corticosterone replacement on the stress-induced 
gastric microcirculation, systemic arterial pressure and gastric erosion were investigated. 
The stress-induced glucocorticoid production was inhibited by a single high dose of cortisol 
injected one week before stress. Gastric microcirculation was evaluated by measurement of 
the blood flow velocity in submucosal and mucosal microvessels (Filaretova et al., 1999).  
Water immersion-restraint stress caused decrease in blood flow velocity in submucosal and 
mucosal gastric microvessels. The deficiency of glucocorticoids during water immersion-
restraint stress promoted the stress-induced decrease of blood flow velocity in submucosal 
and mucosal microvessels, and corticosterone replacement prevented this effect (Filaretova 
et al. 1999, 2004). The results suggest that glucocorticoids released during water immersion-
restraint stress maintain gastric blood flow during the stress. Our data also confirms that the 
decrease in gastric blood flow is associated with the reduction in systemic blood pressure. 
Mean systemic blood pressure in stressed rats with glucocorticoid deficiency was about 60 
mm Hg, and these animals had a very low gastric blood flow velocity and large erosion 
area. Corticosterone replacement increased both systemic blood pressure and gastric blood 
flow and, as a result, improved the resistance of gastric mucosa to ulcerogenic stress action. 
It means that the improvement of gastric blood supply by glucocorticoids is provided, at 
least partly, through their beneficial action on systemic blood circulation. The data suggests 
that the gastroprotective actions of glucocorticoids during water immersion-restraint stress 
may be provided by the maintenance of gastric blood flow that may be brought about by 
their beneficial effect on arterial blood pressure (Filaretova et al. 1999, 2004). 
Thus, glucocorticoids released during activation of the HPA axis may contribute to 
protection of the gastric mucosa by maintaining general body homeostasis, including 
glucose levels and systemic blood pressure, which could be a basis for their beneficial 
influence on gastric mucosal integrity. 
2.4 How gastroprotective action of glucocorticoids may be transformed to 
proulcerogenic one  
Thus, in general glucocorticoid hormones may have dual action on the stomach: 
physiological gastroprotective and pathological proulcerogenic one. In al physiologic 
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conditions, even in acute stress situations, glucocorticoids have an adaptive effect on the 
stomach and, therefore, are gastroprotective, while in some situations their action on the 
gastric mucosa may become proulcerogenic. It is important to understand how 
physiological gastroprotective action can be transformed to pathological proulcerogenic 
effect.  
Because the maintenance of glucose homeostasis by glucocorticoids could be fundamental to 
their gastroprotective action (Filaretova et al., 2002c, 2006), it was reasonable to assume that 
glucocorticoid-induced disturbance of glucose regulation, observed in clinical and 
experimental situations (Subramanian & Trence, 2007, as cited in Filaretova et al., 2009a), 
may contribute to ulcerogenic action of glucocorticoids on the gastric mucosa. We supposed 
that short-term maintenance of blood glucose level provides the gastroprotective action of 
glucocorticoids, while long-lasting maintenance of blood glucose level or long-lasting 
hyperglycemia through a disturbance of carbohydrate regulation may account, at least 
partly, for the ulcerogenic action of glucocorticoids. Thus, we hypothesized that 
glucocorticoid-induced long-lasting maintenance of blood glucose level accompanied by 
their catabolic effects may be responsible for the transformation of gastroprotective action of 
glucocorticoids to their proulcerogenic effect.  
We verified the hypothesis investigating the effects of exogenous glucocorticoid and 
dexamethasone was selected for this aim as synthethic long-acting glucocorticoid. Stress and 
indomethacin were used as ulcerogenic stimuli because both of them are considered as most 
significant ulcerogenic factors in human (Laine et al., 2008). It is important to note that both 
stimuli were applied to rats after 24 hour fasting. Taking into consideration that action of 
exogenous glucocorticoids on the gastric mucosa is depended on the dose (Laine et al., 2008) 
first, we investigated dose-dependent effects of dexamethasone. Surprisingly, 
dexamethasone, even at pharmacological dose 10 mg/kg protected the gastric mucosa 
against stress- and indomethacin-induced injury, at least, during first hour of its action 
(Filaretova et al., 2009a,b). 
Because dexamethasone at the dose of 1 mg/kg decreased the gastric erosion area and 
maintained blood glucose level in fasted stressed or indomethacin-pretreated rats (in the 
case of its injection 1 h before the onset of cold-restraint or indomethacin administration) 
this dose has been selected for the next step, time-dependent study. The results obtained 
demonstrate that single injection of dexamethasone at a dose of 1 mg/kg may attenuate or 
aggravate both cold-restraint- and indomethacin-induced gastric erosion depending on the 
duration of its action before the onset of the stress or indomethacin, respectively. Short-
lasting (1-12 hours) action of dexamethasone attenuated cold-restraint- and indomethacin-
induced gastric ulceration. However long-lasting (21-24 hours) dexamethasone action 
resulted in an aggravation of cold-restraint- and indomethacin-induced gastric erosion 
(Filaretova et al., 2009a,b). The findings suggest that manifestation of gastroprotective or 
ulcerogenic action of glucocorticoids used at the same dose may be dependent very much 
on the time interval between the hormonal injection and onset of ulcerogenic stimulus. 
Prolongation of dexamethasone action may lead to enhancement of gastric mucosal 
susceptibility to ulcerogenic action of cold-restaint or indomethacin. 
Both short- and long-lasting dexamethasone actions resulted in maintenance of blood 
glucose level in fasted stressed and indomethacin-treated rats. Dexamethasone-induced 
long-lasting maintenance of blood glucose level accompanied with the signs of catabolic 
effects. It should be note that dexamethasone-induced increase in the lost of body weight 
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during fasting preceded the appearance of its ulcerogenic action. Thymus weight was used 
as another marker of dexamethasone-induced catabolic effects. It is known that 
glucocorticoids at pharmacological doses tend to kill off many of the thymus cells. This 
phenomenon is the basis for the immunosuppressive use of glucocorticoids (Young et al., 
1981, as cited in Filaretova et al., 2009a). It was shown that dexamethasone accelerates the 
rate of apoptosis in thymocytes (de Belle et al., 1994, as cited in Filaretova et al., 2009a). 
According to our data in distinguish from the body weight changes the thymus weight 
changes started earlier. These findings are in agreement with the data of literature showed 
that metabolic glucocorticoid effects in thymus cells evolve more rapidly comparing those in 
other target cells. The most prominent effect of glucocorticoid in thymus cells is a large 
inhibition of glucose transport that reaches 25-30% by about 30 min after the hormone 
addition. The metabolic inhibitions followed by cell destruction (Young et al., 1981, as cited 
in Filaretova et al., 2009a).  
Dexamethasone treatment inhibited cold-restaint- and indomethacin-induced 
corticosterone production. Because according to our data deficiency of corticosterone 
aggravates cold-restaint- and indomethacin-induced gastric erosion, it is quite possible 
that simultaneous corticosterone deficiency and consequences of disturbances of 
carbohydrate regulation contributed together to proulcerogenic effect of long-lasting 
dexamethasone treatment.  
We prolonged our study till the 7th day to clarify the questions how long dexamethasone 
effects may be continued and whether they are reversible. It was found that the 
dexamethasone-induced proulcerogenic action was continued till the 5th day and then, on 
the 7th day was disappeared. The restoration of stress- or indomethacin-induced 
corticosterone production, which preceded the restoration of normal susceptibility of the 
gastric mucosa to ulcerogenic action of cold-restraint, may contribute to this event. The 
gradual restoration of normal body and spleen weight is a good symptom of reversibility 
dexamethasone-induced catabolic effects. Disappearance of dexamethasone-induced 
maintenance of blood glucose level preceded the restoration of normal body and spleen 
weight.  
In our experimental situations the transformation of gastroprotective action of 
dexamethasone to proulcerogenic one occurred 18 h after its administration, but it is clear 
that in general this time interval depends on many factors, including a kind of 
glucocorticoid and its dose, a specificity of situation. As far back as 1950 it was noted on the 
base of clinical observations that it needs at least 5-7 days of corticosteroids use before 
appearance of ulcer symptoms (Sandweiss, 1954, as cited in Filaretova et al., 2009a). One of 
the principles for minimizing undesirable side effects of glucocorticoid therapy is “keep 
treatment as short as possible, since treatment lasting 5 to 7 days shows fewer side effects” 
(Longui, 2007, as cited in Filaretova et al., 2009a). It is more often glucocorticoid-induced 
ulcer symptoms appeared after much more long hormonal treatment. Our results allow us 
to speculate that glucocorticoid-induced disturbance of carbohydrate regulation, which 
needs time for developing, contributes to appearance of ulcer symptoms after long-lasting 
hormonal therapy. It means that control of glucose regulation and its correction in case of 
need may be considered as useful approach minimizing ulcerogenic side effect of 
glucocorticoid therapy. 
In conclusion, the data obtained so far suggest that short-lasting maintenance of blood 
glucose levels may be responsible for the gastroprotective action of glucocorticoids, while 
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glucocorticoid-induced long-lasting maintenance of blood glucose levels accompanied with 
the signs of their catabolic effect and glucocorticoid-induced corticosterone deficiency may 
be responsible, at least partly, for the transformation of gastroprotective action of 
glucocorticoids to their proulcerogenic effect (Filaretova et al. 2009a, 2009b). Further 
investigation of detailed mechanisms underlying proulcerogenic glucocorticoid action is the 
task of our future studies. We take into consideration other, additional, possibilities for 
explanation the question how physiological gastroprotective action can be transformed to 
pathological proulcerogenic effect. 
3. Conclusion 
According to our data an acute stress-induced increase of glucocorticoids has a 
gastroprotective action against stress-induced gastric injury but is not ulcerogenic, as it has 
generally been considered for some decades. Beneficial action of high levels of endogenous 
glucocorticoids released during acute stress on the stomach is opposite to the harmful 
actions of exogenous glucocorticoids at pharmacological doses used as a hormonal therapy. 
NSAIDs as well as other ulcerogenic stimuli, similar to stress, induce an increase in 
glucocorticoid production that in turn helps the gastric mucosa to resist the harmful actions 
of these stimuli. It is assumed that the adaptive action of glucocorticoids released during 
acute activation of the HPA axis may be applied to the gastric mucosa. Glucocorticoids exert 
gastroprotective actions in co-operation with PGs, NO and capsaicin-sensitive sensory 
neurons: their compensatory gastroprotective action is observed when the protective 
mechanism provided by either of these factors is impared. Gastroprotective effects of 
glucocorticoids may be mediated by multiple actions, including maintenance of gastric 
mucosal blood flow, mucus production, and attenuation of enhanced gastric motility and 
microvascular permeability. The contribution of glucocorticoids to gastroprotection is 
tightly related with their contribution to general body homeostasis. Glucocorticoids released 
during activation of the HPA axis may contribute to protection of the gastric mucosa by 
maintaining general body homeostasis, including glucose levels and systemic blood 
pressure, which could be a basis for their beneficial influence on gastric mucosal integrity. 
These findings further support idea that gastroprotective action of glucocorticoids is an 
essential element of their general adaptive action. In conclusion, the results obtained in our 
studies suggest that glucocorticoids released during acute activation of the HPA axis are 
naturally occurring protective factors that play an important role in maintenance of the 
gastric mucosal integrity. In turn, it means that acute activation of the HPA axis is a 
gastroprotective component of stress response. 
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